Patent ID: 7910708

Claim:
An isolated anti-IL-13 antibody, or antigen-binding fragment thereof, comprising H-CDR1, H-CDR2 and H-CDR3 selected from (i)-(ii): (i) SEQ ID NO: 6, SEQ ID NO:8, and SEQ ID NO: 9, respectively; and (ii) SEQ ID NO: 7, SEQ ID NO:8, and SEQ ID NO: 10, respectively; and comprising L-CDR1, L-CDR2 and L-CDR3 selected from (iii)-(v): (iii) SEQ ID NO: 16. SEQ ID NO: 19, and SEQ ID NO: 20, respectively; (iv) SEQ ID NO: 17, SEQ ID NO: 19, and SEQ ID NO: 21, respectively; and (v) SEQ ID NO: 18. SEQ ID NO: 19, and SEQ ID NO: 22, respectively.